Regulatory T cells in experimental allergic encephalomyelitis. II. T cells functionally antagonistic to encephalitogenic MBP‐specific T cells show persistent expression of FasL
暂无分享,去创建一个
[1] D. Wilson,et al. Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease. , 1999, International immunology.
[2] J. Mountz,et al. Cell death mediated by Fas‐FasL interaction between glial cells and MBP‐reactive T cells , 1998 .
[3] S. Nagata,et al. Essential roles of the Fas ligand in the development of hepatitis , 1997, Nature Medicine.
[4] C. Janeway,et al. The Role of Fas in Autoimmune Diabetes , 1997, Cell.
[5] M. Iwata,et al. Increased Fas antigen on T cells in multiple sclerosis , 1996, Journal of Neuroimmunology.
[6] E. Robinet,et al. Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. , 1996, Journal of immunology.
[7] J. Menonna,et al. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain , 1996, The Journal of experimental medicine.
[8] R. Vabulas,et al. Mechanisms of peripheral T cell deletion: anergized T cells are Fas resistant but undergo proliferation‐associated apoptosis , 1996, European journal of immunology.
[9] D. Green,et al. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. , 1996, Immunity.
[10] G. Mills,et al. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis. , 1996, Cellular immunology.
[11] A. Abbas,et al. Die and Let Live: Eliminating Dangerous Lymphocytes , 1996, Cell.
[12] F. Ramsdell,et al. Fas and FasL in the homeostatic regulation of immune responses. , 1995, Immunology today.
[13] D. Vaux. Ways around rejection , 1995, Nature.
[14] H. Luthra,et al. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. , 1995, Journal of immunology.
[15] J. Tschopp,et al. Down‐modulation of CD4+ T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fasligand interaction , 1995, European journal of immunology.
[16] Warren Strober,et al. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome , 1995, Cell.
[17] H. Maecker,et al. In situ detection and characterization of apoptotic thymocytes in human thymus. Expression of bcl-2 in vivo does not prevent apoptosis. , 1995, Journal of immunology.
[18] C. Thompson,et al. Apoptosis in the pathogenesis and treatment of disease , 1995, Science.
[19] Masato Tanaka,et al. Expression of the functional soluble form of human fas ligand in activated lymphocytes. , 1995, The EMBO journal.
[20] J. Sprent,et al. T-cell apoptosis detected in situ during positive and negative selection in the thymus , 1994, Nature.
[21] P. Erb,et al. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. , 1994, Journal of immunology.
[22] P. Bossù,et al. Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. , 1993, Journal of immunology.
[23] F. Ramsdell,et al. Fas transduces activation signals in normal human T lymphocytes , 1993, The Journal of experimental medicine.
[24] J. Bluestone,et al. Evidence for programmed cell death of self‐reactive γδ T cell receptor‐positive thymocytes , 1993 .
[25] T. Pohl,et al. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. , 1993, Immunology today.
[26] E. Reinherz,et al. Thymic and peripheral apoptosis of antigen‐specific T cells might cooperate in establishing self tolerance , 1993, European journal of immunology.
[27] N. Letvin,et al. Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood. , 1992, The Journal of clinical investigation.
[28] N. Copeland,et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. , 1992, Journal of immunology.
[29] G. Panayi,et al. Limiting dilution analysis of proliferative T cell responses to mycobacterial 65‐kDa heat‐shock protein fails to show significant frequency differences between synovial fluid and peripheral blood of patients with rheumatoid arthritis , 1991, European journal of immunology.
[30] R. Eisenberg,et al. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.
[31] Y. Matsumoto,et al. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis. , 1990, Immunology.
[32] W. Klinkert,et al. Functional heterogeneity among CD4+ encephalitogenic T cells in recruitment of CD8+ T cells in experimental autoimmune encephalomyelitis. , 1989, Journal of immunology.
[33] A. Ben-nun,et al. Regulatory circuits in autoimmunity: recruitment of counter‐regulatory CD8+ T cells by encephalitogenic CD4+ T line cells , 1988, European journal of immunology.
[34] H. Wekerle,et al. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic TT cell interactions , 1988, Nature.
[35] I. Cohen,et al. Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific. , 1983, Journal of immunology.
[36] M. Dallman,et al. Functions of Rat T‐Lymphocyte Subsets Isolated by Means of Monoclonal Antibodies , 1983, Immunological reviews.
[37] I. Cohen,et al. T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells , 1983, European journal of immunology.
[38] I. Cohen,et al. Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein , 1981, Nature.
[39] D. Hinrichs,et al. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction. , 1981, Journal of immunology.
[40] I. Cohen,et al. Vaccination against autoimmune encephalomyelitis (EAE): Attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line , 1981, European journal of immunology.
[41] D. Willenborg. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction. , 1979, Journal of immunology.
[42] R. Swanborg. Antigen-induced inhibition of experimental allergic encephalomyelitis. III. Localization of an inhibitory site distinct from the major encephalitogenic determinant of myelin basic protein. , 1975, Journal of immunology.
[43] R. Swanborg,et al. Studies on the species-variability of experimental allergic encephalomyelitis in guinea pigs and rats. , 1974, Journal of immunology.